Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Renal Failure

  Free Subscription

Articles published in Am J Nephrol

Retrieve available abstracts of 218 articles:
HTML format

Single Articles

    July 2021
  1. PERGOLA PE, Belo D, Crawford P, Moustafa M, et al
    Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
    Am J Nephrol. 2021 Jul 22:1-10. doi: 10.1159/000516012.
    PubMed     Abstract available

  2. DASHPUTRE AA, Sumida K, Thomas F, Gatwood J, et al
    Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.
    Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902.
    PubMed     Abstract available

    June 2021
  3. LIN Z, Liu L, Zhang R, Lin X, et al
    Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Am J Nephrol. 2021 Jun 16:1-12. doi: 10.1159/000516187.
    PubMed     Abstract available

  4. CHOI YS, Lee HS, Joo N, Park P, et al
    Efficacy and Safety of Plastic Cannulae Compared with Metal Needles in the Initial Use of an Arteriovenous Fistulae in Incident Hemodialysis Patients: A Randomized Controlled Study.
    Am J Nephrol. 2021 Jun 10:1-8. doi: 10.1159/000516212.
    PubMed     Abstract available

  5. SHIGEMATSU T, Une Y, Ikejiri K, Kanda H, et al
    Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
    Am J Nephrol. 2021 Jun 7:1-11. doi: 10.1159/000516156.
    PubMed     Abstract available

    May 2021
  6. BANERJEE T, Carrero JJ, McCulloch C, Burrows NR, et al
    Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption.
    Am J Nephrol. 2021 May 27:1-12. doi: 10.1159/000514754.
    PubMed     Abstract available

  7. VODOSEK HOJS N, Ekart R, Bevc S, Piko N, et al
    CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients.
    Am J Nephrol. 2021 May 11:1-8. doi: 10.1159/000516121.
    PubMed     Abstract available

  8. OZCAN C
    Conduction Intervals and Atrial Fibrillation in Chronic Kidney Disease.
    Am J Nephrol. 2021 May 10:1-2. doi: 10.1159/000516153.

  9. SUBRAMANIAN N, Han J, Leeper NJ, Ross EG, et al
    Comparison of Pre-Amputation Evaluation in Patients with and without Chronic Kidney Disease.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516017.
    PubMed     Abstract available

  10. LEE HJ, Kwak N, Kim YC, Choi SM, et al
    Impact of Sleep Duration on Mortality and Quality of Life in Chronic Kidney Disease: Results from the 2007-2015 KNHANES.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516096.
    PubMed     Abstract available

  11. SCOVNER KM, Correa S, Claggett BL, Barrett CD, et al
    Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
    Am J Nephrol. 2021 May 5:1-8. doi: 10.1159/000515670.
    PubMed     Abstract available

    April 2021
  12. BOYER A, Lanot A, Lambie M, Verger C, et al
    Trends in Peritoneal Dialysis Technique Survival, Death, and Transfer to Hemodialysis: A Decade of Data from the RDPLF.
    Am J Nephrol. 2021 Apr 27:1-10. doi: 10.1159/000515472.
    PubMed     Abstract available

  13. MURASHIMA M, Hamano T, Abe M, Masakane I, et al
    Encapsulating Peritoneal Sclerosis and Mortality Related to Infection in Patients on Combination Once-Weekly Hemodialysis with Peritoneal Dialysis.
    Am J Nephrol. 2021 Apr 23:1-6. doi: 10.1159/000515150.
    PubMed     Abstract available

  14. TANTISATTAMO E, Murray V, Obi Y, Park C, et al
    Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.
    Am J Nephrol. 2021 Apr 23:1-14. doi: 10.1159/000513855.
    PubMed     Abstract available

  15. WEI KY, Liao CY, Chung CH, Lin FH, et al
    Carbon Monoxide Poisoning and Chronic Kidney Disease Risk: A Nationwide, Population-Based Study.
    Am J Nephrol. 2021 Apr 22:1-12. doi: 10.1159/000515383.
    PubMed     Abstract available

  16. ALI H, Mohamed MM, Sharma A, Fulop T, et al
    Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2021 Apr 22:1-13. doi: 10.1159/000514454.
    PubMed     Abstract available

  17. PELLA E, Boutou A, Theodorakopoulou MP, Sarafidis P, et al
    Assessment of Exercise Intolerance in Patients with Pre-Dialysis CKD with Cardiopulmonary Function Testing: Translation to Everyday Practice.
    Am J Nephrol. 2021 Apr 21:1-15. doi: 10.1159/000515384.
    PubMed     Abstract available

  18. NAVARRETE JE, Tong DC, Cobb J, Rahbari-Oskoui FF, et al
    Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.
    Am J Nephrol. 2021 Apr 7:1-9. doi: 10.1159/000514752.
    PubMed     Abstract available

    March 2021
  19. FENG Y, Jones MR, Chu NM, Segev DL, et al
    Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis.
    Am J Nephrol. 2021 Mar 31:1-11. doi: 10.1159/000514233.
    PubMed     Abstract available

  20. MOROMIZATO T, Kohagura K, Tokuyama K, Shiohira Y, et al
    Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis.
    Am J Nephrol. 2021 Mar 23:1-11. doi: 10.1159/000513951.
    PubMed     Abstract available

  21. THURLOW JS, Joshi M, Yan G, Norris KC, et al
    Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Am J Nephrol. 2021 Mar 22:1-10. doi: 10.1159/000514550.
    PubMed     Abstract available

  22. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    PubMed     Abstract available

  23. KIM AJ, Ro H, Kim H, Chang JH, et al
    Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Am J Nephrol. 2021 Mar 16:1-12. doi: 10.1159/000513663.
    PubMed     Abstract available

    February 2021
  24. PAI AY, Wenziger C, Streja E, Argueta DA, et al
    Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
    Am J Nephrol. 2021 Feb 18:1-10. doi: 10.1159/000513381.
    PubMed     Abstract available

  25. JIANG J, Zhang Y, Chen J, Yang X, et al
    Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Am J Nephrol. 2021 Feb 17:1-9. doi: 10.1159/000512385.
    PubMed     Abstract available

  26. NANGAKU M, Hamano T, Akizawa T, Tsubakihara Y, et al
    Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
    Am J Nephrol. 2021 Feb 9:1-10. doi: 10.1159/000513103.
    PubMed     Abstract available

  27. SANAI T, Okamura K, Onoue T, Ono T, et al
    Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2021;51:988-994.
    PubMed     Abstract available

    January 2021
  28. OLANIRAN KO, Eneanya ND, Zhao SH, Ofsthun NJ, et al
    Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis.
    Am J Nephrol. 2021 Jan 22:1-9. doi: 10.1159/000513012.
    PubMed     Abstract available

  29. PARK HC, Kwon YE, Choi HY, Oh HJ, et al
    Health Insurance Status Is Related to Risk of Mortality and Hospitalization in Korean Maintenance Hemodialysis Patients: A Longitudinal Cohort Study.
    Am J Nephrol. 2021 Jan 13:1-7. doi: 10.1159/000512855.
    PubMed     Abstract available

    October 2020
    NET Formation in Dialysis: A Valuable, albeit Mysterious and Enticing Predictor of Mortality.
    Am J Nephrol. 2020 Oct 26:1-3. doi: 10.1159/000510772.

  31. EINBINDER Y, Shnaider A, Ghanayem K, Basok A, et al
    Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality.
    Am J Nephrol. 2020 Oct 26:1-9. doi: 10.1159/000510771.
    PubMed     Abstract available

  32. YANG Y, Qin X, Li Y, Yang S, et al
    Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Am J Nephrol. 2020 Oct 16:1-10. doi: 10.1159/000509258.
    PubMed     Abstract available

    September 2020
  33. DANESE MD, Lubeck D, Belozeroff V, Lin TC, et al
    Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
    Am J Nephrol. 2020 Sep 23:1-8. doi: 10.1159/000510360.
    PubMed     Abstract available

  34. BENILLOUCHE E, Ostertag A, Marty C, Urena Torres P, et al
    Cortical Bone Microarchitecture in Dialysis Patients.
    Am J Nephrol. 2020 Sep 10:1-6. doi: 10.1159/000510064.
    PubMed     Abstract available

  35. JOTWANI V, Garimella PS, Katz R, Malhotra R, et al
    Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants.
    Am J Nephrol. 2020 Sep 9:1-9. doi: 10.1159/000509978.
    PubMed     Abstract available

    August 2020
  36. MOORTHI RN, Fadel WF, Cranor A, Hindi J, et al
    Mobility Impairment in Patients New to Dialysis.
    Am J Nephrol. 2020 Aug 11:1-10. doi: 10.1159/000509225.
    PubMed     Abstract available

  37. YOU AS, Kalantar-Zadeh K, Streja E, Park C, et al
    Mortality Risk in Chronic Kidney Disease Patients Transitioning to Dialysis: Impact of Opiate and Non-Opiate Use.
    Am J Nephrol. 2020 Aug 10:1-11. doi: 10.1159/000509451.
    PubMed     Abstract available

  38. LANKINEN R, Hakamaki M, Metsarinne K, Koivuviita NS, et al
    Cardiovascular Determinants of Mortality in Advanced Chronic Kidney Disease.
    Am J Nephrol. 2020 Aug 10:1-10. doi: 10.1159/000509582.
    PubMed     Abstract available

    July 2020
  39. ISHIWATARI A, Yamamoto S, Fukuma S, Hasegawa T, et al
    Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns.
    Am J Nephrol. 2020 Jul 31:1-9. doi: 10.1159/000509309.
    PubMed     Abstract available

  40. SACHDEVA M, Uppal NN, Hirsch JS, Ng JH, et al
    COVID-19 in Hospitalized Patients on Chronic Peritoneal Dialysis: A Case Series.
    Am J Nephrol. 2020 Jul 30:1-5. doi: 10.1159/000510259.
    PubMed     Abstract available

  41. AZIZ F, Ramadorai A, Parajuli S, Garg N, et al
    Obesity: An Independent Predictor of Morbidity and Graft Loss after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 28:1-9. doi: 10.1159/000509105.
    PubMed     Abstract available

  42. ALEXANDROU ME, Balafa O, Sarafidis P
    Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.
    Am J Nephrol. 2020 Jul 27:1-24. doi: 10.1159/000509115.
    PubMed     Abstract available

  43. SCHAMROTH PRAVDA M, Cohen Hagai K, Topaz G, Schamroth Pravda N, et al
    Assessment of the CHA2DS2-VASc Score in Predicting Mortality and Adverse Cardiovascular Outcomes of Patients on Hemodialysis.
    Am J Nephrol. 2020 Jul 22:1-6. doi: 10.1159/000508836.
    PubMed     Abstract available

  44. AGARWAL R, Cramer AE, Balmes-Fenwick M, Sinha AD, et al
    Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.
    Am J Nephrol. 2020;51:542-552.
    PubMed     Abstract available

  45. HETZ P, Pirklbauer M, Muller S, Posch L, et al
    Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 13:1-9. doi: 10.1159/000508957.
    PubMed     Abstract available

  46. CHU NM, Chen X, Norman SP, Fitzpatrick J, et al
    Frailty Prevalence in Younger End-Stage Kidney Disease Patients Undergoing Dialysis and Transplantation.
    Am J Nephrol. 2020 Jul 8:1-10. doi: 10.1159/000508576.
    PubMed     Abstract available

    June 2020
  47. DEBNATH S, Lorenzo C, Bansal S, Morales J, et al
    Branched-Chain Amino Acids Depletion during Hemodialysis Is Associated with Fatigue.
    Am J Nephrol. 2020 Jun 23:1-7. doi: 10.1159/000507839.
    PubMed     Abstract available

  48. LYU B, Hansen KE, Jorgenson MR, Astor BC, et al
    Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
    Am J Nephrol. 2020 Jun 2:1-9. doi: 10.1159/000507470.
    PubMed     Abstract available

    May 2020
  49. WADDY SP, Becerra AZ, Ward JB, Chan KE, et al
    Concomitant Use of Gabapentinoids with Opioids Is Associated with Increased Mortality and Morbidity among Dialysis Patients.
    Am J Nephrol. 2020 May 19:1-9. doi: 10.1159/000507725.
    PubMed     Abstract available

    April 2020
  50. XU X, Wang L, Xiong M, Nie S, et al
    New Criterion to Evaluate Acute-on-Chronic Kidney Injury Based on the Creatinine Reference Change.
    Am J Nephrol. 2020 Apr 29:1-10. doi: 10.1159/000506664.
    PubMed     Abstract available

  51. TUMMALAPALLI SL, Vittinghoff E, Crews DC, Cushman M, et al
    Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study.
    Am J Nephrol. 2020 Apr 29:1-10. doi: 10.1159/000507774.
    PubMed     Abstract available

  52. BHANDARI S, Allgar V, Lamplugh A, Macdougall IC, et al
    Protocol and Baseline Data of a Multicentre Prospective Double-Blinded Randomized Study of Intravenous Iron on Functional Status in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2020 Apr 29:1-8. doi: 10.1159/000507872.
    PubMed     Abstract available

  53. EL SHAMY O, Tran H, Sharma S, Ronco C, et al
    Telenephrology with Remote Peritoneal Dialysis Monitoring during Coronavirus Disease 19.
    Am J Nephrol. 2020 Apr 28:1-3. doi: 10.1159/000508023.

  54. CHU C, Hasan AA, Gaballa MMS, Zeng S, et al
    Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant.
    Am J Nephrol. 2020;51:373-380.
    PubMed     Abstract available

  55. ALI H, Sharma A, Halawa A
    Effect of Interleukin-2 Receptor Antibody Induction Therapy on Survival in Renal Transplant Patients Receiving Tacrolimus.
    Am J Nephrol. 2020 Apr 8:1-7. doi: 10.1159/000506970.
    PubMed     Abstract available

  56. SCHOINA M, Loutradis C, Minopoulou I, Theodorakopoulou M, et al
    Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease.
    Am J Nephrol. 2020 Apr 7:1-10. doi: 10.1159/000507416.
    PubMed     Abstract available

    March 2020
  57. FERREY AJ, Choi G, Hanna RM, Chang Y, et al
    A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
    Am J Nephrol. 2020 Mar 28:1-6. doi: 10.1159/000507417.
    PubMed     Abstract available

  58. RODAS LM, Ruiz-Ortiz E, Garcia-Herrera A, Pereira A, et al
    IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch.
    Am J Nephrol. 2020 Mar 18:1-9. doi: 10.1159/000506853.
    PubMed     Abstract available

  59. WEIR MR, McCullough PA, Buse JB, Anderson J, et al
    Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation
    Am J Nephrol. 2020 Mar 13:1-13. doi: 10.1159/000506533.
    PubMed     Abstract available

  60. BIRUETE A, Srinivasan S, O'Neill KD, Vorland CJ, et al
    Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
    Am J Nephrol. 2020 Mar 6:1-9. doi: 10.1159/000506729.
    PubMed     Abstract available

    February 2020
  61. ALLEGRETTI AS, Endres P, Parris T, Zhao S, et al
    Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit.
    Am J Nephrol. 2020 Feb 25:1-9. doi: 10.1159/000506412.
    PubMed     Abstract available

  62. GIL-ORTEGA M, Vega-Martin E, Martin-Ramos M, Gonzalez-Blazquez R, et al
    Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Fromter Rats, a Genetic Model of Chronic Kidney Disease.
    Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.
    PubMed     Abstract available

  63. UITERWIJK H, Franssen CFM, Kuipers J, Westerhuis R, et al
    Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.
    Am J Nephrol. 2020 Feb 18:1-7. doi: 10.1159/000506324.
    PubMed     Abstract available

  64. LIOUFAS NM, Pedagogos E, Hawley CM, Pascoe EM, et al
    Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the IMpact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Am J Nephrol. 2020 Feb 5:1-15. doi: 10.1159/000505717.
    PubMed     Abstract available

  65. WETMORE JB, Yan H, Gilbertson DT, Liu J, et al
    Factors Associated with Elective Withdrawal of Maintenance Hemodialysis: A Case-Control Analysis.
    Am J Nephrol. 2020 Feb 4:1-10. doi: 10.1159/000505993.
    PubMed     Abstract available

    January 2020
  66. CHOI SJ, Obi Y, Ko GJ, You AS, et al
    Comparing Patient Survival of Home Hemodialysis and Peritoneal Dialysis Patients.
    Am J Nephrol. 2020 Jan 28:1-9. doi: 10.1159/000504691.
    PubMed     Abstract available

  67. ALI W, Gao G, Bakris GL
    Improved Sleep Quality Improves Blood Pressure Control among Patients with Chronic Kidney Disease: A Pilot Study.
    Am J Nephrol. 2020 Jan 24:1-5. doi: 10.1159/000505895.
    PubMed     Abstract available

  68. MORADI H, Park C, Streja E, Argueta DA, et al
    Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Am J Nephrol. 2020 Jan 14:1-10. doi: 10.1159/000505444.
    PubMed     Abstract available

  69. INAMI T, Lyons OD, Perger E, Yadollahi A, et al
    Effect of Ultrafiltration on Sleep Apnea and Cardiac Function in End-Stage Renal Disease.
    Am J Nephrol. 2020 Jan 14:1-8. doi: 10.1159/000505445.
    PubMed     Abstract available

    Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients.
    Am J Nephrol. 2020 Jan 14:1-3. doi: 10.1159/000505446.

  71. SAEED F, Adams H, Epstein RM
    Matters of Life and Death: Why Do Older Patients Choose Conservative Management?
    Am J Nephrol. 2020;51:35-42.
    PubMed     Abstract available

    December 2019
  72. QIAN JZ, McAdams-DeMarco MA, Ng D, Lau B, et al
    Validation of a Risk Equation Predicting Hemodialysis Arteriovenous Fistula Primary Failure in Elderly.
    Am J Nephrol. 2019;51:17-23.
    PubMed     Abstract available

  73. BRAVO GONZALEZ-BLAS L, Garcia-Gago L, Astudillo-Jarrin D, Rodriguez-Magarinos C, et al
    Analysis of Factors Influencing the Prognostic Significance of Hyponatremia in Peritoneal Dialysis Patients.
    Am J Nephrol. 2019 Dec 6:1-11. doi: 10.1159/000504870.
    PubMed     Abstract available

    November 2019
  74. MA Q, Su D, Liu F, Xing H, et al
    Parathyroidectomy Influences Coronary Artery Calcium Score in Asymptomatic Hemodialysis Patients with Secondary Hyperparathyroidism.
    Am J Nephrol. 2019 Nov 26:1-9. doi: 10.1159/000503806.
    PubMed     Abstract available

  75. KITTISKULNAM P, Srijaruneruang S, Chulakadabba A, Thokanit NS, et al
    Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Am J Nephrol. 2019 Nov 21:1-11. doi: 10.1159/000504557.
    PubMed     Abstract available

  76. JAWED A, Moe SM, Moorthi RN, Torke AM, et al
    Increasing Nephrologist Awareness of Symptom Burden in Older Hospitalized End-Stage Renal Disease Patients.
    Am J Nephrol. 2019 Nov 19:1-6. doi: 10.1159/000504333.
    PubMed     Abstract available

    October 2019
  77. GUILLOUET S, Boyer A, Lanot A, Ficheux M, et al
    Assessment for Assisted Peritoneal Dialysis by Peritoneal Dialysis Nurses: Results of a Cohort Study.
    Am J Nephrol. 2019 Oct 31:1-10. doi: 10.1159/000503622.
    PubMed     Abstract available

  78. LEE Y, Okuda Y, Sy J, Kim SR, et al
    Ultrafiltration Rate Effects Declines in Residual Kidney Function in Hemodialysis Patients.
    Am J Nephrol. 2019 Oct 29:1-8. doi: 10.1159/000503918.
    PubMed     Abstract available

  79. CHERNIN G, Chen S, Ozan O, Liu M, et al
    Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Oct 25:1-8. doi: 10.1159/000503916.
    PubMed     Abstract available

  80. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Am J Nephrol. 2019 Oct 25:1-12. doi: 10.1159/000503713.
    PubMed     Abstract available

  81. WU CC, Hsieh MY, Lee CK, Chuang SY, et al
    Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
    Am J Nephrol. 2019 Oct 22:1-11. doi: 10.1159/000503949.
    PubMed     Abstract available

  82. MODI GK, Jha V
    Disparate Chronic Kidney Disease-Associated Outcomes in South Asians Ethnicity or Estimated Glomerular Filtration Rate?
    Am J Nephrol. 2019 Oct 22:1-3. doi: 10.1159/000503874.

  83. FIRTH C, Kaur T, Chakkera H, Zhang N, et al
    Cardiac Troponin T and Right Ventricular Systolic Pressure Predict Cardiovascular and Mortality Risk in Kidney Transplant Candidates.
    Am J Nephrol. 2019 Oct 22:1-10. doi: 10.1159/000503807.
    PubMed     Abstract available

  84. LI T, Wilcox CS, Lipkowitz MS, Gordon-Cappitelli J, et al
    Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
    Am J Nephrol. 2019 Oct 18:1-11. doi: 10.1159/000503805.
    PubMed     Abstract available

  85. NADEAU-FREDETTE AC, Chan CT, Bargman JM, Copland MA, et al
    Predictors of Care Gaps in Home Dialysis: The Home Dialysis Virtual Ward Study.
    Am J Nephrol. 2019 Oct 10:1-9. doi: 10.1159/000503439.
    PubMed     Abstract available

    September 2019
  86. ERIGUCHI R, Obi Y, Soohoo M, Rhee CM, et al
    Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Am J Nephrol. 2019 Sep 13:1-9. doi: 10.1159/000502998.
    PubMed     Abstract available

  87. HARA T, Kimachi M, Ikenoue T, Akizawa T, et al
    Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan.
    Am J Nephrol. 2019 Sep 5:1-9. doi: 10.1159/000502633.
    PubMed     Abstract available

  88. LU Y, Wang Y, Lu Q
    Effects of Exercise on Muscle Fitness in Dialysis Patients: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2019 Sep 3:1-12. doi: 10.1159/000502635.
    PubMed     Abstract available

  89. SCHEFOLD JC, Krag M, Marker S, Perner A, et al
    Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
    Am J Nephrol. 2019 Sep 3:1-8. doi: 10.1159/000502732.
    PubMed     Abstract available

    August 2019
  90. GHOSHAL S, Freedman BI
    Mechanisms of Stroke in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Aug 28:1-11. doi: 10.1159/000502446.
    PubMed     Abstract available

  91. HUANG M, Lv A, Wang J, Xu N, et al
    Exercise Training and Outcomes in Hemodialysis Patients: Systematic Review and Meta-Analysis.
    Am J Nephrol. 2019 Aug 27:1-15. doi: 10.1159/000502447.
    PubMed     Abstract available

  92. NORDYKE RJ, Reichert H, Bylsma LC, Jackson JJ, et al
    Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage.
    Am J Nephrol. 2019 Aug 21:1-9. doi: 10.1159/000502507.
    PubMed     Abstract available

  93. BUGEJA A, Harris S, McCormick B, Brown PA, et al
    Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis.
    Am J Nephrol. 2019 Aug 21:1-7. doi: 10.1159/000502506.
    PubMed     Abstract available

  94. AL-BALAS A, Shariff S, Lee T, Young C, et al
    Clinical Outcomes and Economic Impact of Starting Hemodialysis with a Catheter after Predialysis Arteriovenous Fistula Creation.
    Am J Nephrol. 2019 Aug 8:1-7. doi: 10.1159/000502050.
    PubMed     Abstract available

  95. LEWIS JR, Wong G, Taverniti A, Vucak-Dzumhur M, et al
    Association between Aortic Calcification, Cardiovascular Events, and Mortality in Kidney and Pancreas-Kidney Transplant Recipients.
    Am J Nephrol. 2019 Aug 8:1-10. doi: 10.1159/000502328.
    PubMed     Abstract available

  96. COURI T, Katz J, Stoeckle K, Nugooru A, et al
    Provider Attitudes toward the Use of Hepatitis C Virus-Positive Organs in Kidney Transplantation.
    Am J Nephrol. 2019 Aug 7:1-9. doi: 10.1159/000502049.
    PubMed     Abstract available

    July 2019
  97. HUML AM, Sehgal AR
    Hemodialysis Quality Metrics in the First Year Following a Failed Kidney Transplant.
    Am J Nephrol. 2019 Jul 16:1-7. doi: 10.1159/000501605.
    PubMed     Abstract available

  98. WONG E, Ballew SH, Daya N, Ishigami J, et al
    Hospitalization Risk among Older Adults with Chronic Kidney Disease.
    Am J Nephrol. 2019 Jul 16:1-9. doi: 10.1159/000501539.
    PubMed     Abstract available

  99. KU E, McCulloch CE, Johansen KL
    Starting Renal Replacement Therapy: Is It About Time?
    Am J Nephrol. 2019 Jul 3:1-8. doi: 10.1159/000501510.
    PubMed     Abstract available

    June 2019
  100. FARRINGTON CA, Allon M
    Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism.
    Am J Nephrol. 2019 Jun 26:1-7. doi: 10.1159/000501357.
    PubMed     Abstract available

  101. CANNEY M, Djurdjev O, Tang M, Zierold C, et al
    GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 25:1-10. doi: 10.1159/000501189.
    PubMed     Abstract available

  102. DAVIS-AJAMI ML, Fink JC, Baernholdt M, Wu J, et al
    Adverse Safety Event Characteristics and Predictive Factors in Hospital Encounters for Patients with Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 19:1-9. doi: 10.1159/000500562.
    PubMed     Abstract available

  103. WEINHANDL ED, Ray D, Kubisiak KM, Collins AJ, et al
    Contemporary Trends in Clinical Outcomes among Dialysis Patients with Medicare Coverage.
    Am J Nephrol. 2019 Jun 14:1-9. doi: 10.1159/000500943.
    PubMed     Abstract available

  104. OKADA Y, Uehara S, Shibata M, Koh H, et al
    Habitual Alcohol Intake Modifies Relationship of Uric Acid to Incident Chronic Kidney Disease.
    Am J Nephrol. 2019 Jun 6:1-8. doi: 10.1159/000500707.
    PubMed     Abstract available

  105. GREGG LP, Jain N, Carmody T, Minhajuddin AT, et al
    Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes.
    Am J Nephrol. 2019 Jun 5:1-11. doi: 10.1159/000500668.
    PubMed     Abstract available

  106. LEE J, Chu C, Guzman D, Fontil V, et al
    Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes.
    Am J Nephrol. 2019 Jun 5:1-7. doi: 10.1159/000500706.
    PubMed     Abstract available

    May 2019
  107. KUIPERS J, Verboom LM, Ipema KJR, Paans W, et al
    The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis.
    Am J Nephrol. 2019;49:497-506.
    PubMed     Abstract available

    Redefining the Burden of Intradialytic Hypotension in the Modern Era of Hemodialysis.
    Am J Nephrol. 2019;49:494-496.

  109. PARMAR DV, Kansagra KA, Patel JC, Joshi SN, et al
    Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study.
    Am J Nephrol. 2019;49:470-478.
    PubMed     Abstract available

  110. DREW DA, Tighiouart H, Duncan S, Rollins J, et al
    Blood Pressure and Cognitive Decline in Prevalent Hemodialysis Patients.
    Am J Nephrol. 2019;49:460-469.
    PubMed     Abstract available

    April 2019
  111. GORAYA N, Munoz-Maldonado Y, Simoni J, Wesson DE, et al
    Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
    Am J Nephrol. 2019;49:438-448.
    PubMed     Abstract available

  112. IBARRA-HERNANDEZ M, Alcantar-Vallin ML, Soto-Cruz A, Jimenez-Alvarado PM, et al
    Challenges in Managing Pregnancy in Underserved Women with Chronic Kidney Disease.
    Am J Nephrol. 2019;49:386-396.
    PubMed     Abstract available

  113. KAPOIAN T, Khalil S, O'Mara NB, Brink DM, et al
    Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.
    Am J Nephrol. 2019;49:368-376.
    PubMed     Abstract available

  114. JOTWANI VK, Lee AK, Estrella MM, Katz R, et al
    Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
    Am J Nephrol. 2019;49:346-355.
    PubMed     Abstract available

    March 2019
  115. MATSCHKAL J, Mayer CC, Sarafidis PA, Lorenz G, et al
    Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients.
    Am J Nephrol. 2019;49:317-327.
    PubMed     Abstract available

  116. RIVERA M, Tamariz L, Suarez M, Contreras G, et al
    Modifying Effect of Statins on Fatal Outcomes in Chronic Kidney Disease Patients in the Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Am J Nephrol. 2019;49:297-306.
    PubMed     Abstract available

  117. STRUGNELL SA, Sprague SM, Ashfaq A, Petkovich M, et al
    Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Am J Nephrol. 2019;49:284-293.
    PubMed     Abstract available

  118. AKIZAWA T, Macdougall IC, Berns JS, Bernhardt T, et al
    Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
    Am J Nephrol. 2019;49:271-280.
    PubMed     Abstract available

    February 2019
  119. JOVANOVICH A, You Z, Isakova T, Nowak K, et al
    Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
    Am J Nephrol. 2019;49:263-270.
    PubMed     Abstract available

  120. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Temporal Trends in Incident Mortality in Dialysis Patients: Focus on Sex and Racial Disparities.
    Am J Nephrol. 2019;49:241-253.
    PubMed     Abstract available

  121. EMRICH IE, Brandenburg V, Sellier AB, Schauerte J, et al
    Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Am J Nephrol. 2019;49:203-211.
    PubMed     Abstract available

  122. WANDELL P, Carlsson AC, Li X, Gasevic D, et al
    End-Stage Kidney Diseases in Immigrant Groups: A Nationwide Cohort Study in Sweden.
    Am J Nephrol. 2019;49:186-192.
    PubMed     Abstract available

    January 2019
  123. AKIZAWA T, Nangaku M, Yamaguchi T, Arai M, et al
    A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Am J Nephrol. 2019;49:165-174.
    PubMed     Abstract available

  124. BYLSMA LC, Reichert H, Gage SM, Roy-Chaudhury P, et al
    Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.
    Am J Nephrol. 2019;49:156-164.
    PubMed     Abstract available

  125. SCHWANTES-AN TH, Liu S, Stedman M, Decker BS, et al
    Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
    Am J Nephrol. 2019;49:125-132.
    PubMed     Abstract available

  126. PRASAD PV, Li LP, Thacker JM, Li W, et al
    Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.
    Am J Nephrol. 2019;49:114-124.
    PubMed     Abstract available

  127. JIANG K, Lerman LO
    Prediction of Chronic Kidney Disease Progression by Magnetic Resonance Imaging: Where Are We?
    Am J Nephrol. 2019;49:111-113.

  128. OLANIRAN KO, Eneanya ND, Allegretti AS, Zhao SH, et al
    Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.
    Am J Nephrol. 2019;49:93-102.
    PubMed     Abstract available

  129. PEREZ FERNANDEZ M, Martinez Miguel P, Ying H, Haugen CE, et al
    Comorbidity, Frailty, and Waitlist Mortality among Kidney Transplant Candidates of All Ages.
    Am J Nephrol. 2019;49:103-110.
    PubMed     Abstract available

  130. KRAHN RE, Tulowitzki R, Gudleski GD, Murray B, et al
    Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Am J Nephrol. 2019;49:74-80.
    PubMed     Abstract available

  131. CHEUNG CK, Barratt J
    Pregnancy in IgA Nephropathy: An Effect on Renal Outcome?
    Am J Nephrol. 2019;49:212-213.

  132. COURI T, Cotter TG, Chen D, Hammes M, et al
    Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago.
    Am J Nephrol. 2019;49:32-40.
    PubMed     Abstract available

    December 2018
  133. AJMAL F, Probst J, Brooks J, Hardin J, et al
    Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Am J Nephrol. 2018;49:64-73.
    PubMed     Abstract available

  134. DAUBRESSE M, Alexander GC, Crews DC, Segev DL, et al
    Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014.
    Am J Nephrol. 2018;49:20-31.
    PubMed     Abstract available

  135. YE X, Kooman JP, van der Sande FM, Canaud B, et al
    Increased Mortality Associated with Higher Pre-Dialysis Serum Sodium Variability: Results of the International MONitoring Dialysis Outcome Initiative.
    Am J Nephrol. 2018;49:1-10.
    PubMed     Abstract available

  136. LEE T, Qian J, Thamer M, Allon M, et al
    Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis Patients.
    Am J Nephrol. 2018;49:11-19.
    PubMed     Abstract available

    November 2018
  137. BURROWS NR, Vassalotti JA, Saydah SH, Stewart R, et al
    Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.
    Am J Nephrol. 2018;48:447-455.
    PubMed     Abstract available

  138. AWAN AA, Niu J, Pan JS, Erickson KF, et al
    Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
    Am J Nephrol. 2018;48:472-481.
    PubMed     Abstract available

  139. GUILLOTEAU S, Lobbedez T, Guillouet S, Verger C, et al
    Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2018;48:425-433.
    PubMed     Abstract available

  140. FITZPATRICK J, Sozio SM, Jaar BG, McAdams-DeMarco MA, et al
    Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis.
    Am J Nephrol. 2018;48:406-414.
    PubMed     Abstract available

  141. KO GJ, Obi Y, Soohoo M, Chang TI, et al
    No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.
    Am J Nephrol. 2018;48:389-398.
    PubMed     Abstract available

  142. JANSZ TT, van Reekum FE, Ozyilmaz A, de Jong PA, et al
    Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.
    Am J Nephrol. 2018;48:369-377.
    PubMed     Abstract available

    October 2018
  143. LYU B, Banerjee T, Scialla JJ, Shafi T, et al
    Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
    Am J Nephrol. 2018;48:330-338.
    PubMed     Abstract available

  144. BIKOS A, Angeloudi E, Memmos E, Loutradis C, et al
    A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.
    Am J Nephrol. 2018;48:295-305.
    PubMed     Abstract available

  145. KOSMADAKIS G, Albaret J, da Costa Correia E, Somda F, et al
    Gastrointestinal Disorders in Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;48:319-325.
    PubMed     Abstract available

  146. CHEN YJ, Yeung L, Sun CC, Huang CC, et al
    Age-Related Macular Degeneration in Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Am J Nephrol. 2018;48:278-291.
    PubMed     Abstract available

  147. JADOON A, Mathew AV, Byun J, Gadegbeku CA, et al
    Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.
    Am J Nephrol. 2018;48:269-277.
    PubMed     Abstract available

  148. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
    Am J Nephrol. 2018;48:260-268.
    PubMed     Abstract available

    September 2018
  149. AZMANDIAN J, Abbasi MR, Pourfarziani V, Nasiri AA, et al
    Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.
    Am J Nephrol. 2018;48:251-259.
    PubMed     Abstract available

  150. FIRTH C, Shamoun F, Cha S, Zhang N, et al
    Cardiac Troponin T Risk Stratification Model Predicts All-Cause Mortality Following Kidney Transplant.
    Am J Nephrol. 2018;48:242-250.
    PubMed     Abstract available

  151. HAUGEN CE, King EA, Bae S, Bowring MG, et al
    Early Hospital Readmission in Older and Younger Kidney Transplant Recipients.
    Am J Nephrol. 2018;48:235-241.
    PubMed     Abstract available

  152. THADHANI R, Guilatco R, Hymes J, Maddux FW, et al
    Switching from Epoetin Alfa (Epogen(R)) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.
    Am J Nephrol. 2018;48:214-224.
    PubMed     Abstract available

  153. HAYASHI T, Yasuda K, Kimura T, Sasaki K, et al
    Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:205-213.
    PubMed     Abstract available

  154. GARZA-MAYERS AC, Shah R, Sykes DB, Nigwekar SU, et al
    The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis.
    Am J Nephrol. 2018;48:168-171.
    PubMed     Abstract available

  155. WARSAME F, Ying H, Haugen CE, Thomas AG, et al
    Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients.
    Am J Nephrol. 2018;48:181-189.
    PubMed     Abstract available

  156. ZOCCALI C, Mallamaci F
    A New Treatment for Calciphylaxis in Hemodialysis Patients?
    Am J Nephrol. 2018;48:165-167.

  157. AGARWAL R, Rossignol P, Garza D, Mayo MR, et al
    Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.
    Am J Nephrol. 2018;48:172-180.
    PubMed     Abstract available

  158. SHINFUKU A, Shimazaki T, Fujiwara M, Sato F, et al
    Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers.
    Am J Nephrol. 2018;48:157-164.
    PubMed     Abstract available

    August 2018
  159. KERNS ES, Kim ED, Meoni LA, Sozio SM, et al
    Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients.
    Am J Nephrol. 2018;48:147-156.
    PubMed     Abstract available

    Changes in Total Protein Concentration Due to Fluid Removal During and Shortly after Hemodialysis.
    Am J Nephrol. 2018;48:118-126.
    PubMed     Abstract available

  161. DROSOS G, Ampatzidou F, Sarafidis P, Karaiskos T, et al
    Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.
    Am J Nephrol. 2018;48:108-117.
    PubMed     Abstract available

  162. IKENOUE T, Koike K, Fukuma S, Ogata S, et al
    Salt Intake and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;48:87-95.
    PubMed     Abstract available

  163. MOVILLI E, Camerini C, Gaggia P, Zubani R, et al
    Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Am J Nephrol. 2018;48:79-86.
    PubMed     Abstract available

    July 2018
  164. ZHOU H, Yang M, Jiang Z, Ding J, et al
    Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:46-55.
    PubMed     Abstract available

  165. AIRY M, Schold JD, Jolly SE, Arrigain S, et al
    Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.
    Am J Nephrol. 2018;48:36-45.
    PubMed     Abstract available

  166. BOSTOM A, Pasch A, Madsen T, Roberts MB, et al
    Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Am J Nephrol. 2018;48:21-31.
    PubMed     Abstract available

  167. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Gender and Racial Disparities in Initial Hemodialysis Access and Outcomes in Incident End-Stage Renal Disease Patients.
    Am J Nephrol. 2018;48:4-14.
    PubMed     Abstract available

    June 2018
  168. BLUM D, Chan CT
    Iatrogenesis Imperfecta Medicamentosa: Adverse Drug Events in Dialysis Patients are Associated with Higher Resource Utilization and Mortality.
    Am J Nephrol. 2018;47:438-440.

  169. CHAN L, Saha A, Poojary P, Chauhan K, et al
    National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions.
    Am J Nephrol. 2018;47:441-449.
    PubMed     Abstract available

  170. DOSHI S, Wish JB
    Can Emergency Department Visits for Adverse Drug Reactions in Dialysis Patients be Reduced?
    Am J Nephrol. 2018;47:435-437.

  171. LEE T, Shah S, Leonard AC, Parikh P, et al
    Acute Kidney Injury before Dialysis Initiation Predicts Adverse Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:427-434.
    PubMed     Abstract available

  172. FERREY A, You AS, Kovesdy CP, Nakata T, et al
    Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.
    Am J Nephrol. 2018;47:415-423.
    PubMed     Abstract available

  173. MARUYAMA N, Otsuki T, Yoshida Y, Nagura C, et al
    Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
    Am J Nephrol. 2018;47:406-414.
    PubMed     Abstract available

  174. GREGG LP, Tio MC, Li X, Adams-Huet B, et al
    Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Am J Nephrol. 2018;47:395-405.
    PubMed     Abstract available

    May 2018
  175. YANG X, Tong Y, Yan H, Ni Z, et al
    High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Am J Nephrol. 2018;47:317-324.
    PubMed     Abstract available

  176. KLEINE CE, Soohoo M, Ranasinghe ON, Park C, et al
    Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
    Am J Nephrol. 2018;47:333-342.
    PubMed     Abstract available

  177. IWASHITA Y, Ohya M, Yashiro M, Sonou T, et al
    Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Am J Nephrol. 2018;47:325-332.
    PubMed     Abstract available

    April 2018
  178. ZOCCALI C, Mallamaci F
    Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:251-253.

  179. BEBERASHVILI I, Katkov A, Sinuani I, Azar A, et al
    Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;47:254-265.
    PubMed     Abstract available

  180. CHAN CT, Kaysen GA, Beck GJ, Li M, et al
    Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Am J Nephrol. 2018;47:208-217.
    PubMed     Abstract available

    March 2018
  181. NORMAND G, Xu X, Panaye M, Jolivot A, et al
    Pregnancy Outcomes in French Hemodialysis Patients.
    Am J Nephrol. 2018;47:219-227.
    PubMed     Abstract available

  182. TAN J, Mehrotra A, Nadkarni GN, He JC, et al
    Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:200-207.
    PubMed     Abstract available

  183. CHEN W, Bushinsky DA
    Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables?
    Am J Nephrol. 2018;47:171-173.

  184. CREWS DC, Banerjee T, Wesson DE, Morgenstern H, et al
    Race/Ethnicity, Dietary Acid Load, and Risk of End-Stage Renal Disease among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:174-181.
    PubMed     Abstract available

  185. KALANTAR-ZADEH K, Parameswaran V, Ficociello LH, Anderson L, et al
    Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
    Am J Nephrol. 2018;47:153-161.
    PubMed     Abstract available

    February 2018
  186. PATZER RE, Basu M, Smith KD, Plantinga L, et al
    Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting.
    Am J Nephrol. 2018;47:115-119.
    PubMed     Abstract available

  187. KIM JK, Song YR, Lee HS, Kim HJ, et al
    Repeated Bioimpedance Measurements Predict Prognosis of Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;47:120-129.
    PubMed     Abstract available

  188. WISH JB, Aronoff GR, Bacon BR, Brugnara C, et al
    Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
    Am J Nephrol. 2018;47:72-83.
    PubMed     Abstract available

  189. SINGH M, Raghavan D, Williams JS, Martin BC, et al
    Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.
    Am J Nephrol. 2018;47:67-71.
    PubMed     Abstract available

    January 2018
  190. SUMIDA K, Yamamoto S, Akizawa T, Fukuhara S, et al
    Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2018;47:48-56.
    PubMed     Abstract available

  191. CHIN MP, Bakris GL, Block GA, Chertow GM, et al
    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
    Am J Nephrol. 2018;47:40-47.
    PubMed     Abstract available

  192. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Abstract available

    December 2017
  193. DIVANI M, Georgianos PI, Didangelos T, Iliadis F, et al
    Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Am J Nephrol. 2017;47:21-29.
    PubMed     Abstract available

    Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
    Am J Nephrol. 2017;47:18-20.

  195. JONES D, You Z, Kendrick JB
    Racial/Ethnic Differences in Barriers to Kidney Transplant Evaluation among Hemodialysis Patients.
    Am J Nephrol. 2017;47:1-7.
    PubMed     Abstract available

  196. MC CAUSLAND FR, Claggett B, Pfeffer MA, Burdmann EA, et al
    Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
    Am J Nephrol. 2017;46:488-497.
    PubMed     Abstract available

    November 2017
  197. KIDO R, Akizawa T, Fukagawa M, Onishi Y, et al
    Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.
    Am J Nephrol. 2017;46:439-447.
    PubMed     Abstract available

  198. SUMIDA K, Diskin CD, Molnar MZ, Potukuchi PK, et al
    Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Am J Nephrol. 2017;46:397-407.
    PubMed     Abstract available

  199. CATABAY C, Obi Y, Streja E, Soohoo M, et al
    Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:408-416.
    PubMed     Abstract available

  200. MALHOTRA R, Tao X, Wang Y, Chen Y, et al
    Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.
    Am J Nephrol. 2017;46:390-396.
    PubMed     Abstract available

  201. TOMINAGA N, Kida K, Inomata T, Sato N, et al
    Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Am J Nephrol. 2017;46:417-426.
    PubMed     Abstract available

    October 2017
  202. WEIR MR, Pergola PE, Agarwal RL, Fink JC, et al
    A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:364-370.
    PubMed     Abstract available

  203. MADUELL F, Varas J, Ramos R, Martin-Malo A, et al
    Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Am J Nephrol. 2017;46:288-297.
    PubMed     Abstract available

  204. LAM NN, Garg AX, Knoll GA, Kim SJ, et al
    Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
    Am J Nephrol. 2017;46:343-354.
    PubMed     Abstract available

    September 2017
  205. SAULNIER PJ, Dieter BP, Tanamas SK, McPherson SM, et al
    Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Am J Nephrol. 2017;46:276-284.
    PubMed     Abstract available

  206. MUREA M, Brown WM, Divers J, Moossavi S, et al
    Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
    Am J Nephrol. 2017;46:268-275.
    PubMed     Abstract available

  207. LEONBERG-YOO AK, Rudnick MR
    Tobacco Use: A Chronic Kidney Disease Accelerant.
    Am J Nephrol. 2017;46:257-259.

  208. ROEHM B, Simoni J, Pruszynski J, Wesson DE, et al
    Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Am J Nephrol. 2017;46:260-267.
    PubMed     Abstract available

  209. LIN MC, Streja E, Soohoo M, Hanna M, et al
    Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Am J Nephrol. 2017;46:249-256.
    PubMed     Abstract available

    August 2017
  210. HARDING K, Mersha TB, Pham PT, Waterman AD, et al
    Health Disparities in Kidney Transplantation for African Americans.
    Am J Nephrol. 2017;46:165-175.
    PubMed     Abstract available

    May 2017
  211. FERREIRA A, Felipe C, Cristelli M, Viana L, et al
    Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Am J Nephrol. 2017;45:497-508.
    PubMed     Abstract available

    January 2017
  212. KOVESDY CP, Furth SL, Zoccali C
    Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Am J Nephrol. 2017;45:283-291.
    PubMed     Abstract available

  213. PAYAN SCHOBER F, Jobson MA, Poulton CJ, Singh HK, et al
    Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.
    Am J Nephrol. 2017;45:248-256.
    PubMed     Abstract available

  214. COLLISTER D, Sathianathan C, Ryz K, Karpinski M, et al
    ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series.
    Am J Nephrol. 2017;45:209-216.
    PubMed     Abstract available

    Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?
    Am J Nephrol. 2017;46:285-287.

  216. QIU W, Jiang Y, Wu J, Huang H, et al
    Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function.
    Am J Nephrol. 2017;45:82-88.
    PubMed     Abstract available

  217. HEMPEL JC, Poppelaars F, Gaya da Costa M, Franssen CF, et al
    Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    Am J Nephrol. 2017;45:49-59.
    PubMed     Abstract available

    December 2016
  218. TABER DJ, Fleming JN, Fominaya CE, Gebregziabher M, et al
    The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.
    Am J Nephrol. 2016;45:91-98.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.